2023-11-09T18:17:50-06:00 2022-12-31 410746749 CLIFTONLARSONALLEN LLP 901 NORTH GLEBE ROAD SUITE 200 ARLINGTON VA 22203 990 2022-01-01 237045686 INFECTIOUS DISEASES SOCIETY OF AMERICA INFE 7032990200 4040 WILSON BOULEVARD 300 ARLINGTON VA 22203 BARTON GROH VP, FINANCE & ADMINISTRATION 7032990200 2023-11-08 1 BARTON GROH 999009999 0 ROBERT WILLIAMS P01345960 5715793002 2023-11-03 2 AAL1 IAL1 2022 2023-04-26 12:10:37Z IDSA CHRISTOPHER BUSKY 4040 WILSON BOULEVARD 300 ARLINGTON VA 22203 39036452 0 X WWW.IDSOCIETY.ORG X 1970 DC TO PROMOTE EXCELLENCE IN THE PREVENTION AND CARE OF INFECTIOUS DISEASES. 15 15 114 700 515175 173136 4196838 3384750 22776192 29484170 4130064 830955 455126 601336 31558220 34301211 470572 893650 0 0 10093926 12893010 0 0 0 12266072 19067040 22830570 32853700 8727650 1447511 64244197 66632887 10892330 19191188 53351867 47441699 X THE INFECTIOUS DISEASES SOCIETY OF AMERICA (IDSA) IS A COMMUNITY OF OVER 12,000 PHYSICIANS, SCIENTISTS AND PUBLIC HEALTH EXPERTS WHO SPECIALIZE IN INFECTIOUS DISEASES. OUR PURPOSE IS TO IMPROVE THE HEALTH OF INDIVIDUALS, COMMUNITIES, AND SOCIETY BY PROMOTING EXCELLENCE IN PATIENT CARE, EDUCATION, RESEARCH, PUBLIC HEALTH, AND PREVENTION RELATING TO INFECTIOUS DISEASES. 0 0 IDWEEK ANNUAL CONFERENCE - IN 2022, OVER 10,000 PARTICIPANTS AND EXHIBITORS ATTENDED EITHER IN PERSON OR VIRTUALLY. IDWEEK IS THE WORLD'S PREMIER INFECTIOUS DISEASES EVENT. IDWEEK PROVIDES AN OPPORTUNITY FOR HEALTH PROFESSIONALS OF VARIED BACKGROUNDS TO LEARN FROM EACH OTHER'S KNOWLEDGE, EXPERIENCE AND EXPERTISE, FOR THE IMPROVEMENT OF PATIENT CARE AND PUBLIC HEALTH. THIS IS AN INCLUSIVE MEETING THAT OFFERS ACCESS TO INTERNATIONALLY RECOGNIZED LEADERS IN THE FIELD AND THE OPPORTUNITY TO NETWORK WITH THE MOST HIGHLY RESPECTED HEALTH PROFESSIONALS IN INFECTIOUS DISEASES, INCLUDING HIV. CLINICAL INFECTIOUS DISEASES (CID), THE JOURNAL OF INFECTIOUS DISEASES (JID) AND OPEN FORUM INFECTIOUS DISEASES (OFID) ARE SCHOLARLY JOURNALS PUBLISHED BY IDSA IN PARTNERSHIP WITH AN OUTSIDE PUBLISHER TO DISSEMINATE THE LATEST RESEARCH ON A VARIETY OF TOPICS IN THE FIELD TO MEMBERS AND SUBSCRIBERS. CID PUBLISHES ORIGINAL RESEARCH, REVIEWS AND PERSPECTIVES THAT ALL CLINICIANS CAN USE WHEN CARING FOR PATIENTS. CID COVERS THE CLINICAL PRESENTATION, DIAGNOSIS, TREATMENT AND PREVENTION OF THE FULL RANGE OF INFECTIOUS DISEASES. THE EVALUATION OF CURRENT AND NOVEL TREATMENTS, MICROBIOLOGY, IMMUNOLOGY AND POLICIES AS THEY RELATE TO PATIENT CARE ARE HIGHLY PRIORITIZED. PUBLISHED CONTINUOUSLY SINCE 1904, JID IS THE PREMIER GLOBAL JOURNAL FOR TRANSLATIONAL INFECTIOUS DISEASES SCIENCE. THE EDITORS WELCOME MAJOR ARTICLES AND BRIEF REPORTS DESCRIBING RESEARCH RESULTS ON MICROBIOLOGY, IMMUNOLOGY, EPIDEMIOLOGY, AND RELATED DISCIPLINES, ON THE PATHOGENESIS, DIAGNOSIS, AND TREATMENT OF INFECTIOUS DISEASES; ON THE MICROBES THAT CAUSE THEM; AND ON DISORDERS OF HOST IMMUNE RESPONSES. OFID PUBLISHES CLINICAL, TRANSLATIONAL AND BASIC RESEARCH IN A FULLY OPEN ACCESS, ONLINE JOURNAL. IT FOCUSES ON THE INTERSECTION OF BIOMEDICAL SCIENCE AND CLINICAL PRACTICE, WITH AN EMPHASIS ON KNOWLEDGE THAT COULD IMPROVE PATIENT CARE GLOBALLY. ARTICLES ARE WRITTEN BY EXPERTS IN THE FIELD, INCLUDING MEMBERS AND NON-MEMBERS, AND REVIEWED BY A PANEL OF LEADING MEDICAL EXPERTS BEFORE THEY ARE PUBLISHED. IDSA WAS AWARDED A COOPERATIVE AGREEMENT TO SUPPORT THE CDC BY PROVIDING RESOURCES TO FRONTLINE HEALTH CARE PROFESSIONALS CARING FOR PATIENTS WITH COVID-19. THE PARTNERSHIP BRINGS NUMEROUS MEDICAL SPECIALTIES TOGETHER TO SHARE RESOURCES AND TO PROVIDE THE LATEST INFORMATION AND GUIDANCE ON TREATING THOSE INFECTED WITH COVID-19 AND PREVENTING ITS SPREAD. THROUGH FUNDING FROM CDC, IDSA EXPERTS SUPPORT CDC'S CLINICAL CALL LINES, PROVIDING GUIDANCE TO HEALTH CARE PROVIDERS TREATING COVID-19 PATIENTS. THE COLLABORATION HAS ALSO FUNDED THE FLOURISHING COVID-19 REAL-TIME LEARNING NETWORK, AN ONLINE CENTER FOR FRONTLINE CLINICIANS TO LEARN, COLLABORATE AND SHARE TREATMENT BEST PRACTICES. IDSA'S COVID-19 PRACTICE GUIDELINES ON DIAGNOSTICS, TREATMENT AND MANAGEMENT ALSO RECEIVE FUNDING THROUGH THE GRANT. ADDITIONALLY, UNDER THE PARTNERSHIP, TWICE-MONTHLY CLINICIAN TELECONFERENCES PROVIDE HEALTH CARE PROFESSIONALS ACCESS TO EXPERTS WITH THE LATEST INFORMATION ON THIS EVOLVING VIRUS AS WELL AS AN OPPORTUNITY TO ASK QUESTIONS. THE CALLS FREQUENTLY DRAW MORE THAN 800 ATTENDEES. 0 1 0 1 0 0 0 0 0 1 1 0 1 1 0 0 0 0 0 1 0 0 0 0 0 0 1 1 1 0 0 0 0 0 0 0 0 0 0 0 1 1 0 0 1 223 0 1 114 1 1 1 0 0 0 1 1 0 0 0 X 15 15 0 0 0 0 1 1 1 1 1 0 0 1 1 1 1 1 1 1 1 0 X BARTON GROH VP FINANCE & ADMIN 7032990200 4040 WILSON BOULEVARD NO 300 ARLINGTON VA 22203 CHRIS BUSKY CEO 35.50 2.00 X 563970 31773 53805 TY JOHNSON COO (START DATE OF 4-1-22) 25.00 12.50 X 188373 94186 9558 SANDRA VURA HARWOOD VP, MTG. EDU. 37.50 0.00 X 268031 0 19990 DANA WOLLINS VP, CLINICAL AFFR. & GUIDE 37.50 0.00 X 261409 0 23045 AMANDA JEZEK SVP, POLICY & GOV. REL. 37.50 0.00 X 262642 0 21782 FELICITY CLANCY VP, MKT. / MEMBE. 37.50 0.00 X 236730 0 20480 BARTON GROH VP, FIN. & ADMIN 30.50 1.00 X 227939 7474 18280 SALANDRA THOMAS VP, TALENT / ORGA. DEVEL. 34.50 1.00 X 230475 6653 15575 ANDREA WEDDLE ED, HIVMA 36.50 1.00 X 220384 6038 15515 MICHAEL CUMMINS SR DIR, PROJECT MANAGEMENT AND GRANTS 37.50 0.00 X 185087 0 16431 RACHEL SHNEKENDORF SR DIR, EDUCATION 37.50 0.00 X 170319 0 12443 CARLOS DEL RIO MD FIDSA PRESIDENT 2.00 0.00 X X 0 0 0 STEVEN K SCHMITT MD FIDSA PRESIDENT-ELECT 2.00 0.00 X X 0 0 0 TINA Q TAN MD FIDSA VICE PRESIDENT 2.00 0.00 X X 0 0 0 JEFFREY S DUCHIN MD FIDSA SECRETARY 2.00 0.00 X X 0 0 0 JEANNE MARRAZZO MD FIDSA TREASURER 2.00 2.00 X X 0 0 0 DAN P MCQUILLEN MD FIDSA IMMEDIATE PAST PRESIDENT 2.00 0.00 X X 5000 0 0 LILIAN M ABBO MD FIDSA MEMBER 2.00 0.00 X 0 0 0 ADAORA A ADIMORA MD FIDSA MEMBER 2.00 0.00 X 0 0 0 CESAR A ARIAS MD FIDSA MEMBER 2.00 0.00 X 0 0 0 WENDY ARMSTRONG MD FIDSA MEMBER 2.00 0.00 X 0 0 0 MAXIMO O BRITO MD FIDSA MEMBER 2.00 0.00 X 0 0 0 RANA CHAKRABORTY MD MSC DPHIL FID MEMBER 2.00 0.00 X 0 0 0 RAJESH T GHANDI MD FIDSA MEMBER 2.00 0.00 X 0 0 0 JASMINE MARCELIN MD FIDSA MEMBER 2.00 0.00 X 0 0 0 ROBIN TROTTMAN DO FIDSA MEMBER 2.00 0.00 X 0 0 0 BONNIE M WORD MD FIDSA MEMBER 2.00 0.00 X 0 0 0 ANGELA M CALENDO MD PHD FIDSA MEMBER 2.00 0.00 X 0 0 0 BARBARA ALEXANDER MD MHS FIDSA MEMBER 2.00 0.00 X 0 0 0 KIMBERLY E HANSON MD MEMBER 2.00 0.00 X 0 0 0 JOHN B LYNCH II MD MPH FIDSA MEMBER 2.00 0.00 X 0 0 0 2820359 146124 226904 26 0 1 0 HART HEALTH STRATEGIES 3823 FORDHAM RD NW WASHINGTON DC 20016 CONSULTING 295000 PAUL E SAX MD 78 CROWNINSHIELD ROAD BROOKLINE MA 02446 CONSULTING 162600 LEVERAGE NON-PROFIT STRATEGIES LLC 136 ELLINGTON DRIVE SCHAUMBURG IL 60194 CONSULTING 138603 SHARON STEVENS 13 SUMMIT SQUARE CT 166 LANGHORNE PA 19047 CONSULTING 113200 DRASHTI LLC 25527 BERESFORD DRIVE CHANTILLY VA 20152 CONSULTING 113100 5 3384750 3384750 ANNUAL MEETING 900099 14657509 14657509 JOURNALS 900099 9090052 9090052 MEMBERSHIP DUES 900099 2936189 2936189 MANAGEMENT FEES 900099 1863617 1863617 EDUCATION PROGRAMS 900099 838803 838803 98000 98000 29484170 816196 816196 86161 86161 4750000 4735241 14759 14759 14759 CAREER CENTER 900099 294861 294861 WEBSITE ADS 900099 220314 220314 515175 34301211 29484170 515175 917116 X 650000 242150 1500 1943998 8978540 421452 867554 681466 26921 57372 138261 9248732 2637 818045 528524 907619 94719 6773831 323649 146730 32853700 5922287 2940822 705970 1608795 3705879 6034144 339662 741714 4028996 1764005 2582954 2264991 50197806 40460434 4524580 789639 8057407 64244197 66632887 2062787 4189557 6170401 5001749 2659142 9999882 10892330 19191188 X 53351867 47441699 53351867 47441699 64244197 66632887 1447511 -7357679 0 X 0 1 X 1 1 1 RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED 0 0 1 3317211 744982 -1111716 -366734 1061508 -1428242 2034916 485597 1549319 1994080 1278408 715672 2264991 PRIVATELY HELD SEC. 4524580 F 4524580 457 ASSET 156149 DUE FROM AFFILIATE 379763 SECURITY DEPOSIT 78720 4040 LEASE 7442775 8057407 457 LIABILITY 156149 LEASE LIABILITY 9843733 9999882 EAST ASIA AND THE PACIFIC 0 8 PROGRAM SERVICES EDITORIAL REVIEW, HONORARIUMS, SUBSCRIPTION SERVICE 26605 EUROPE (INCLUDING ICELAND & GREENLAND) 0 11 PROGRAM SERVICES EDITORIAL REVIEW, HONORARIUMS, JOURNAL PUBLISHING, TRAVEL REIMBURSEMENTS 225013 MIDDLE EAST AND NORTH AFRICA 0 3 PROGRAM SERVICES TRAVEL REIMBURSEMENTS 6500 NORTH AMERICA 0 7 PROGRAM SERVICES CONSULTING, CONTENT CREATION, HONORARIUMS, AND TRAVEL REIMBURSEMENTS 215559 RUSSIA AND NEIGHBORING STATES 0 1 GRANTS TO RECIPIENTS GRANTS 1500 SOUTH AMERICA 0 1 PROGRAM SERVICES TRAVEL REIMBURSEMENTS 456 0 31 0 0 0 31 475633 0 475633 0 0 0 0 0 1 PART III ACCOUNTING METHOD: 1 MONTEFIORE MEDICAL CENTER 111 E 210TH STREET BRONX NY 10467 131740114 501(C)(3) 100000 0 LEAP AWARD UNIVERSITY OF MARYLAND 22 S GREENE STREET BALTIMORE MD 21201 521362793 501(C)(3) 100000 0 LEAP AWARD SEATTLE CHILDREN'S HOSPITAL PO BOX 5371 MS RC-507 SEATTLE WA 98145 943164280 501(C)(3) 100000 0 LEAP AWARD UNIVERSITY OF NEBRASKA CENTER 42ND AND EMILE STREETS OMAHA NE 68198 470049123 501(C)(3) 100000 0 LEAP AWARD IDSA EDUCATION AND RESEARCH FOUNDATION 4040 WILSON BLVD STE 300 ARLINGTON VA 22203 311765388 501(C)(3) 250000 0 PROGRAM SERVICE ACCOMPLISHMENTS 5 0 CLINICAL TEACHER AWARD 2 3000 OSWALD AVERY AWARD 1 1500 SOCIETY CITATION AWARD 3 7500 RESEARCH AWARD 1 1500 CITATION AWARD 1 1500 FELLOWS TRAVEL GRANTS 286 225550 GUERRANT TRAVEL GRANTS 1 1600 PART I, LINE 2: TRAVEL GRANTS AND AWARDS ARE DISBURSED AT MEETINGS; WIRES ARE SENT POST-MEETING ATTENDANCE CONFIRMATION. RESEARCH AND FELLOWSHIPS ARE REQUIRED TO SUBMIT WRITTEN RESULTS POST AWARD PERIOD. X X X X 0 1 0 CHRIS BUSKY CEO 444192 25025 119778 6748 0 0 43197 2434 7738 436 614905 34643 0 0 TY JOHNSON COO (START DATE OF 4-1-22) 155527 77763 32846 16423 0 0 6301 3150 0 107 194674 97443 0 0 SANDRA VURA HARWOOD VP, MTG. EDU. 248031 0 20000 0 0 0 13874 0 6116 0 288021 0 0 0 DANA WOLLINS VP, CLINICAL AFFR. & GUIDE 241409 0 20000 0 0 0 13673 0 9372 0 284454 0 0 0 AMANDA JEZEK SVP, POLICY & GOV. REL. 242642 0 20000 0 0 0 13628 0 8154 0 284424 0 0 0 FELICITY CLANCY VP, MKT. / MEMBE. 216730 0 20000 0 0 0 12328 0 8152 0 257210 0 0 0 BARTON GROH VP, FIN. & ADMIN 208574 6839 19365 635 0 0 11685 383 6015 197 245639 8054 0 0 SALANDRA THOMAS VP, TALENT / ORGA. DEVEL. 211038 6117 19437 536 0 0 11658 338 3478 101 245611 7092 0 0 ANDREA WEDDLE ED, HIVMA 200917 5505 19467 533 0 0 11180 306 3922 107 235486 6451 0 0 MICHAEL CUMMINS SR DIR, PROJECT MANAGEMENT AND GRANT 162267 0 22820 0 0 0 9358 0 7073 0 201518 0 0 0 RACHEL SHNEKENDORF SR DIR, EDUCATION 167472 0 2847 0 0 0 8869 0 3574 0 182762 0 0 0 PART I, LINE 3 CEO COMPENSATION: THE IDSA BOARD HAS ENTERED INTO AN EMPLOYMENT CONTRACT WITH ITS CHIEF EXECUTIVE OFFICER. THE COMPENSATION DETAILED IN THE CONTRACT AND SUBSEQUENT RAISES DURING THE CONTRACT TERM ARE BASED ON A REVIEW OF 990'S FROM OTHER SIMILAR NON-PROFIT ORGANIZATIONS, A COMPENSATION STUDY WRITTEN EMPLOYMENT CONTRACTS OF OTHER SIMILARILY SITUATED EXCECUTIVES, AND ANNUAL APPROVAL BY THE EXECUTIVE COMMITTEE. PART I, LINE 4B THE ORGANIZATION CONTRIBUTED $29,598 TO 457 PLANS FOR THE BENEFIT OF THE CEO. FORM 990, PART VI, SECTION A, LINE 1A THE EXECUTIVE COMMITTEE OF THE BOARD OF DIRECTORS CONSISTS OF THE PRESIDENT, VP, PRESIDENT-ELECT, PAST PRESIDENT, SECRETARY, & TREASURER - ARE RESPONSIBLE FOR THE MANAGEMENT AND DIRECTION OF THE ORGANIZATION AND CONDUCT THE AFFAIRS OF THE ORGANIZATION DURING INTERVALS BETWEEN MEETINGS OF THE BOD, FOR ASSISTING THE PRESIDENT IN THE OVERSIGHT OF THE ADMINISTRATIVE INFRASTRUCTURE OF THE SOCIETY, FOR SERVICE AS AN ADVISORY BODY TO THE PRESIDENT, AND FOR REPORTING ALL OF ITS ACTIONS TO THE BOD FOR REVIEW AND/OR APPROVAL. FORM 990, PART VI, SECTION A, LINE 6 THE CATEGORIES OF MEMBERSHIP INCLUDE: MEMBER, FELLOW, MEMBER-IN-TRAINING, ASSOCIATE MEMBER, AND MEDICAL STUDENT OR RESIDENT MEMBER. SOME MEMBERS OR FELLOWS MAY BE FURTHER CLASSIFIED AS HONORARY OR EMERITUS. FORM 990, PART VI, SECTION A, LINE 7A ALL MEMBERS OF THE BOARD OF DIRECTORS ARE SELECTED BY A LEADERSHIP DEVELOPMENT COMMITTEE OF MEMBERS BY REVIEWING CLINICAL EXPERIENCE, SERVICE WITHIN IDSA GOVERNANCE STRUCTURE AND APPLYING PRINCIPLES OF INCLUSION, DIVERSITY, ACCESS AND EQUITY. THE SLATE OF NEW BOARD MEMBER IS THEN APPROVED BY THE BOARD AND ULTIMATELY BY THE FULL MEMBERSHIP. MEMBERS, MEMBERS-IN-TRAINING AND FELLOWS ARE FULL VOTING MEMBERS OF THE SOCIETY. FORM 990, PART VI, SECTION A, LINE 7B THE BYLAWS MAY BE AMENDED BY THE AFFIRMATIVE VOTE OF AT LEAST TWO-THIRDS (2/3) OF DIRECTORS PRESENT AND VOTING AT ANY REGULAR OR SPECIAL MEETING OF THE BOARD OF DIRECTORS. UPON THE WRITTEN REQUEST OF AT LEAST 10% OF THE VOTING MEMBERS, AN AMENDMENT MAY BE SUBMITTED TO THE BOARD OF DIRECTORS FOR CONSIDERATION AND VOTE AT THE NEXT BOARD OF DIRECTORS' MEETING. IF THE BOARD OF DIRECTORS DECIDE NOT TO PASS ANY MEMBER-PROPOSED AMENDMENT, THE BOARD OF DIRECTORS WILL SUBMIT THE MEMBER-PROPOSED AMENDMENT TO THE FULL MEMBERSHIP AT THE NEXT MEETING OF THE MEMBERS, AND SUCH MEMBER-PROPOSED AMENDMENT MAY BE ADOPTED BY THE AFFIRMATIVE VOTE OF AT LEAST TWO-THIRDS OF THE VOTING MEMBERS OF THE CORPORATION, PRESENT AND VOTING AT ANY REGULAR OR SPECIAL MEETING OF SUCH MEMBERS, IF NOTICE OF THE PROPOSED AMENDMENT IS CONTAINED IN THE NOTICE OF THE MEETING; OR BY AFFIRMATIVE VOTE OF AT LEAST TWO-THIRDS OF THOSE VOTING BY MAIL BALLOT. BYLAWS AMENDMENTS APPROVED BY THE BOARD OF DIRECTORS SHALL BE COMMUNICATED TO THE MEMBERS WITHIN SIXTY (60) DAYS OF APPROVAL. FORM 990, PART VI, SECTION B, LINE 11B THE 990 IS REVIEWED BY THE CEO, COO AND VP OF FINANCE AND ADMINISTRATION. A COPY OF THE 990 IS THEN PROVIDED TO EACH MEMBER OF THE BOARD OF DIRECTORS BEFORE IT IS FILED. FORM 990, PART VI, SECTION B, LINE 12C IDSA REQUIRES THAT ALL VOLUNTEERS FOR OUR BOARD AND COMMITTEES SUBMIT A CONFLICT OF INTEREST (COI) FORM ON AN ANNUAL BASIS. TOP EMPLOYEES ARE ALSO REQUIRED TO SUBMIT A COI ON AN ANNUAL BASIS. IN THE EVENT THAT A MEMBER WOULD HAVE A CONFLICT RELATED TO ANY DISCUSSION/VOTE, THE MEMBER IS REQUIRED TO ABSTAIN FROM PARTICIPATING IN THE DISCUSSION/VOTE. IF STAFF WOULD HAVE A CONFLICT WITH AN AREA OR COMPANY WE ARE WORKING WITH, THE STAFF MEMBER WOULD NOT BE ALLOWED TO WORK ON/WITH THE PROJECT INVOLVING THAT AREA OR COMPANY. THE COI ETHICS COMMITTEE IS TASKED WITH MONITORING COMPLIANCE WITH THE POLICY. WHEN A CONFLICT ARISES, ANY CONFLICTED BOARD MEMBER ABSTAINS FROM VOTING ON THE MATTER.STAFF COIS ARE VIEWED BY THE CEO AND HE DETERMINES WHEN THIS MIGHT BE THE CASE. THE CEO CONFLICT REPORT IS SHARED WITH THE EXECUTIVE COMMITTEE OF THE BOARD AND THEY WOULD DETERMINE IF THE CEO HAS A CONFLICT. FORM 990, PART VI, SECTION B, LINE 15 CEO COMPENSATION: (A) REVIEW AND APPROVAL IS DONE BY THE EXECUTIVE COMMITTEE, MEETING IN EXECUTIVE SESSION, (B) COMPARABILITY DATA IS OBTAINED FROM ASAE AND USED FOR DETERMINING COMPENSATION, (C) THERE ARE NO MINUTES OF THE EXECUTIVE SESSION, SO NO WRITTEN DELIBERATION. WRITTEN DECISION IS FORWARDED TO THE VP OF FINANCE AND ADMINISTRATION TO PLACE IN PERSONNEL FILE AND APPLIED TO PAYROLL. STAFF COMPENSATION: (A) REVIEW IS DONE BY THE EMPLOYEE SUPERVISOR AND APPROVAL IS DONE BY THE CEO (BOARD APPROVES THE OVERALL SALARY BUDGET, NOT INDIVIDUALS, EXCEPT FOR THE CEO), (B) COMPARABILITY DATA IS OBTAINED FROM ASAE AND USED FOR DETERMINING COMPENSATION, (C) EMPLOYEE PERFORMANCE REVIEWS ARE WRITTEN UP AND SIGNED BY THE REVIEWER BEFORE THE REVIEW HAPPENS AND THE EMPLOYEE BEING REVIEWED SIGNS AFTER IT IS DONE. THIS WRITTEN REVIEW IS USED TO SUBSTANTIATE ANY STAFF SALARY CHANGE TO THE CEO. FORM 990, PART VI, SECTION C, LINE 19 THE GOVERNING DOCUMENTS AND CONFLICT OF INTEREST POLICY ARE AVAILABLE ON THE SOCIETY'S WEBSITE. UPON REQUEST, THEY ARE MADE AVAILABLE BASED ON BUSINESS NEED. THE AUDITED FINANCIAL STATEMENTS ARE AVAILABLE ON THE SOCIETY'S WEBSITE. FORM 990, PART IX, LINE 11G CID SUPPLEMENT 161,185. SPEAKER HONORARIA 1,462,684. WEBSITE DEVELOPMENT CONSULTANTS 417,984. CLINICAL ON CALL 1,406,038. EDITORIAL 60,875. OTHER CONSULTING 5,432,909. ID SPECIALTY PROMOTION 307,057. IDSA EDUCATION AND RESEARCH FOUNDATION 4040 WILSON BLVD STE 300 ARLINGTON VA 22203 311765388 FUNDING INITIATIVES DEDICATED TO SUPPORTING IDSA'S MISSION WORLDWIDE VA 501(C)(3) LINE 12A, I INFECTIOUS DISEASES SOCIETY OF AMERICA 1 0 1 0 0 0 0 0 0 0 0 0 0 0 1 1 0 0 0 0 IDSA EDUCATION AND RESEARCH FOUNDATION B 250000 COST IDSA EDUCATION AND RESEARCH FOUNDATION O 1010750 COST IDSA EDUCATION AND RESEARCH FOUNDATION N 220690 COST